References
- Lader M. Benzodiazepine withdrawal states. In: Trimble MR, ed. Benzodiazepines divided. New York: John Wiley & Sons, 1983:17–31
- Schatzberg AF, Haddad P, Kaplan EM, et al. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus Panel. J Clin Psychiatry 1997; 58(Suppl7):5–10
- Black K, Shea C, Dursun S, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 2000;25(3): 255–61
- Haddad P. Newer antidepressants and the discontinuation syndrome. J Clin Psychiatry 1997; 58(Suppl 7): 17–22
- Richelson E. Pharmacology of antidepressants. Mayo Clin Prue 2001; 76(5): 511–27
- Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16(5): 356–62
- Kaplan EM. Antidepressant noncompliance as a factor in the discontinuation syndrome. J Clin Psychiatry 1997; 58(Suppl 7):31–6
- Rosenbaum JF, Zajecka J. Clinical management of antidepressant discontinuation. J Clin Psychiatry 1997;58(Suppl 7):37–40
- Lejoyeux M, Ades J. Antidepressant discontinuation: a review of the literature. J Clin Psychiatry 1997; 58(Suppl 7): 11–6
- Schatzberg AF, Haddad P, Kaplan EM, et al. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. J Clin Psychiatry 1997; 58(Suppl 7):23–7
- Lazowick AL, Levin GM. Potential withdrawal syndrome associated with SSRI discontinuation. Ann Pharmacother 1995;29(12): 1284–5
- Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram—a review of pharmacological and clinical effects. J Psychiatry Neurosci 2000; 25(3): 241–54